Authors:
ROWINSKY EK
NOE DA
GROCHOW LB
SARTORIOUS SE
BOWLING MK
CHEN TL
LUBEJKO BG
KAUFMANN SH
DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDIES OF PYRAZOLOACRIDINE, A NOVEL DNA INTERCALATING AGENT, ON SINGLE-DOSING AND MULTIPLE-DOSING SCHEDULES, Journal of clinical oncology, 13(8), 1995, pp. 1975-1984
Authors:
ROWINSKY EK
GROCHOW LB
ETTINGER DS
SARTORIUS SE
LUBEJKO BG
CHEN TL
ROCK MK
DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF THE NOVEL TOPOISOMERASE-I INHIBITOR 1-PIPERIDINO)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN (CPT-11) ADMINISTERED AS A 90-MINUTE INFUSION EVERY 3 WEEKS, Cancer research, 54(2), 1994, pp. 427-436
Authors:
ROWINSKY EK
CHAUDHRY V
FORASTIERE AA
SARTORIUS SE
ETTINGER DS
GROCHOW LB
LUBEJKO BG
CORNBLATH DR
DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF PACLITAXEL AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR - NEUROMUSCULAR TOXICITY IS DOSE-LIMITING, Journal of clinical oncology, 11(10), 1993, pp. 2010-2020
Authors:
ROWINSKY EK
NOE DA
ETTINGER DS
CHRISTIAN MC
LUBEJKO BG
FISHMAN EK
SARTORIUS SE
BOYD MR
DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF THE PULMONARY CYTOTOXIN 4-IPOMEANOL ON A SINGLE DOSE SCHEDULE IN LUNG-CANCER PATIENTS - HEPATOTOXICITYIS DOSE LIMITING IN HUMANS, Cancer research, 53(8), 1993, pp. 1794-1801
Authors:
ROWINSKY EK
GROCHOW LB
HENDRICKS CB
ETTINGER DS
FORASTIERE AA
HUROWITZ LA
MCGUIRE WP
SARTORIUS SE
LUBEJKO BG
KAUFMANN SH
DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN - A NOVEL TOPOISOMERASE-I INHIBITOR, Journal of clinical oncology, 10(4), 1992, pp. 647-656